|
|
Bristol myers Squibb Company (BMY) |
|
|
|
| |
BMY's Revenue Growth by Quarter and Year
Bristol Myers Squibb's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BMY Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
11,477.00
|
11,406.00
|
11,985.00
|
| III Quarter |
September |
-
|
10,966.00
|
11,218.00
|
11,624.00
|
| II Quarter |
June |
12,201.00
|
11,226.00
|
11,887.00
|
11,703.00
|
| I Quarter |
March |
11,865.00
|
11,337.00
|
11,648.00
|
11,073.00
|
| FY |
|
24,066.00
|
45,006.00
|
46,159.00
|
46,385.00
|
| BMY Revenue second quarter 2024 Y/Y Growth Comment |
Bristol myers Squibb Company achieved in the second quarter 2024, above Company average Revenue improvement of 8.69% year on year, to $ 12,201.00 millions.
Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 51 other companies have achieved higher Revenue growth. While Bristol Myers Squibb Company' s Revenue increase of 8.69% ranks overall at the positon no. 764 in the second quarter 2024.
|
| BMY Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
0.62 % |
-4.83 % |
8.29 % |
| III Quarter |
September |
- |
-2.25 % |
-3.49 % |
10.28 % |
| II Quarter |
June |
8.69 % |
-5.56 % |
1.57 % |
15.54 % |
| I Quarter |
March |
4.66 % |
-2.67 % |
5.19 % |
2.71 % |
| FY |
|
- |
-2.5 % |
-0.49 % |
9.09 % |
BMY Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
4.66 % |
1.68 % |
3.11 % |
| III Quarter |
September |
- |
-2.32 % |
-5.63 % |
-0.68 % |
| II Quarter |
June |
2.83 % |
-0.98 % |
2.05 % |
5.69 % |
| I Quarter |
March |
3.38 % |
-0.6 % |
-2.81 % |
0.05 % |
| FY (Year on Year) |
|
- |
-2.5 % |
-0.49 % |
9.09 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 82.11 % |
5.85 % |
-30.1 % |
| (Mar 31 2020) |
|
|
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 82.11 % |
5.85 % |
-30.1 % |
| (Mar 31 2020) |
|
|
|
| Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Bristol Myers Squibb's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 35.7 % |
1.39 % |
-15.91 % |
| (Mar 31 2020) |
|
|
| BMY's II. Quarter Q/Q Revenue Comment |
Bristol myers Squibb Company achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.83%, to $ 12,201.00 millions, from $11,865.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 361. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 35.7 % |
1.39 % |
-15.91 % |
| (Mar 31 2020) |
|
|
| BMY's II. Quarter Q/Q Revenue Comment |
Bristol myers Squibb Company achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.83%, to $ 12,201.00 millions, from $11,865.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 361. |
|
Bristol Myers Squibb's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Revenue 12 Months Ending |
$ 46,509.00 |
$ 45,534.00 |
$ 45,006.00 |
$ 44,935.00 |
$ 45,187.00 |
| Y / Y Revenue Growth (TTM) |
2.93 % |
-0.68 % |
-2.5 % |
-3.86 % |
-4.15 % |
| Year on Year Revenue Growth Overall
Ranking |
# 693 |
# 209 |
# 1657 |
# 155 |
# 288 |
| Seqeuential Revenue Change (TTM) |
2.14 % |
1.17 % |
0.16 % |
-0.56 % |
-1.44 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 415 |
# 1666 |
# 1859 |
# 180 |
# 2214 |
| Cumulative Revenue growth
Comment |
Although Bristol Myers Squibb's Annual Revenue growth year on year were below company's average 5.53% , Revenue announced in the Jun 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.93% year on year, from -0.68% in Mar 31 2024.
In the Healthcare sector 74 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 209 to 693. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.53 % |
-24.59 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.53 % |
-24.59 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 14 |
| Sector |
# 45 |
| S&P 500 |
# 415 |
|
| Cumulative Revenue growth
Comment |
Although Bristol Myers Squibb's Annual Revenue growth year on year were below company's average 5.53% , Revenue announced in the Jun 30 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.93% year on year, from -0.68% in Mar 31 2024.
In the Healthcare sector 74 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 209 to 693. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.53 % |
-24.59 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.53 % |
-24.59 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 14 |
| Sector |
# 45 |
| S&P 500 |
# 415 |
|
15.20%